| Current Price | $61.60 | Mkt Cap | $77.3B |
|---|---|---|---|
| Open | $61.00 | P/E Ratio | 17.13 |
| Prev. Close | $61.60 | Div. (Yield) | $2.92 (4.7%) |
| Daily Range | $60.81 - $61.71 | Volume | 10 |
| 52-Wk Range | $57.17 - $74.12 | Avg. Daily Vol. | 6,805,650 |
A biopharmaceutical company that discovers, develops and commercializes innovative therapeutics in areas of unmet medical need.
| Current Price | $61.60 | Mkt Cap | $77.3B |
|---|---|---|---|
| Open | $61.00 | P/E Ratio | 17.13 |
| Prev. Close | $61.60 | Div. (Yield) | $2.92 (4.7%) |
| Daily Range | $60.81 - $61.71 | Volume | 10 |
| 52-Wk Range | $57.17 - $74.12 | Avg. Daily Vol. | 6,805,650 |
The best Bull and Bear pitches based on recency and number of recommendations.
This company has proved that it can cure diseases. It has over $30B in cash. Good mgmt. Good yield. As of today at has a P/E of 7. If this company was not here tomorrow, people would notice.
I have a real hard time imagining that Gilead will have sold enough Remdesivir to make this stock a market performer much less a market *beater.* I do continue to own shares in my real portfolio though, so I'm happy to be proven wrong. Underperform.
Read the most recent pitches from players about GILD.
Recs
Katstu5860
(51.87)
Submitted: 3/10/2022 4:15:14 PM :
Start Price:
$57.59
NASDAQ:GILD Score:
+10.48
Large moat industry with modest inflationary protection with above market dividends
Recs
spainDC
(49.90)
Submitted: 2/25/2022 5:16:09 PM :
Start Price:
$60.14
NASDAQ:GILD Score:
+6.82
good quality and value
Recs
TMFjimhalley
(< 20)
Submitted: 4/16/2021 11:47:44 PM :
Start Price:
$64.53
NASDAQ:GILD Score:
-3.77
Despite declining HIV drug sales, the company's growing oncology pipeline will help it increase revenue.
Find the members with the highest scoring picks in GILD.
BrianMotleyFool (71.64) Score: +536.73
The Score Leader is the player with the highest score across all their picks in GILD.
|
Top Pick |
Member Name |
Member Rating |
Start Date |
Call |
Time Frame |
Start Price |
Stock Gain |
Index Gain |
Score | Commentary |
|---|---|---|---|---|---|---|---|---|---|---|
| janleszek | < 20 | 3/30/2009 |
|
3M | $18.03 | +241.69% | +423.44% | +181.76 | 0 Comment | |
| WilliamCrook2003 | 72.23 |
|
|
5Y | $12.82 | +380.38% | +208.33% | +172.05 | 1 Comment | |
| UrineLuck73 | 40.20 | 1/29/2007 |
|
NS | $12.82 | +380.38% | +208.33% | +172.05 | 0 Comment | |
| predragj | 39.25 | 1/30/2007 |
|
NS | $12.99 | +374.30% | +207.98% | +166.32 | 0 Comment | |
| mxdfool | < 20 | 12/15/2006 |
|
5Y | $13.05 | +372.13% | +206.92% | +165.21 | 0 Comment | |
| betsypurcell | < 20 | 1/24/2007 |
|
NS | $13.07 | +371.48% | +206.65% | +164.83 | 0 Comment | |
| leoladot | < 20 | 1/5/2009 |
|
3M | $21.26 | +189.80% | +354.13% | +164.33 | 1 Comment | |
| rmarinchek | < 20 | 1/25/2007 |
|
3W | $13.16 | +367.94% | +204.79% | +163.15 | 0 Comment | |
| Redskins2k9 | < 20 | 1/25/2007 |
|
5Y | $13.16 | +367.94% | +204.79% | +163.15 | 0 Comment | |
| opveiby | 79.44 | 1/25/2007 |
|
5Y | $13.16 | +367.94% | +204.79% | +163.15 | 0 Comment |
See what the Wall Street professionals think, according to their public statements and filings.
